LeBoeuf NR - Search Results

1

Update on the management of high-risk squamous cell carcinoma.

LeBoeuf NR, Schmults CD. LeBoeuf NR, et al. Semin Cutan Med Surg. 2011 Mar;30(1):26-34. doi: 10.1016/j.sder.2011.02.002. Semin Cutan Med Surg. 2011. PMID: 21540018 Review.

2

Immune Profiling of Dermatologic Adverse Events from Checkpoint Blockade using Tissue Cyclic Immunofluorescence.

Maliga Z, Kim DY, Bui AN, Lin JR, Dewan AK, Murphy GF, Nirmal AJ, Lian CG, Sorger PK, LeBoeuf NR. Maliga Z, et al. Among authors: leboeuf nr. bioRxiv [Preprint]. 2023 Apr 5:2023.04.03.535435. doi: 10.1101/2023.04.03.535435. bioRxiv. 2023. Update in: J Invest Dermatol. 2024 Feb 14:S0022-202X(24)00107-6. doi: 10.1016/j.jid.2024.01.024. PMID: 37066161 Free PMC article. Updated. Preprint.

3

Update on the biology and clinical management of Merkel cell carcinoma.

Thakuria M, LeBoeuf NR, Rabinowits G. Thakuria M, et al. Among authors: leboeuf nr. Am Soc Clin Oncol Educ Book. 2014:e405-10. doi: 10.14694/EdBook_AM.2014.34.e405. Am Soc Clin Oncol Educ Book. 2014. PMID: 24857131 Free article. Review.

4

High-throughput sequencing of the T cell receptor β gene identifies aggressive early-stage mycosis fungoides.

de Masson A, O'Malley JT, Elco CP, Garcia SS, Divito SJ, Lowry EL, Tawa M, Fisher DC, Devlin PM, Teague JE, Leboeuf NR, Kirsch IR, Robins H, Clark RA, Kupper TS. de Masson A, et al. Among authors: leboeuf nr. Sci Transl Med. 2018 May 9;10(440):eaar5894. doi: 10.1126/scitranslmed.aar5894. Sci Transl Med. 2018. PMID: 29743350 Free PMC article.

5

Chromosome 3q arm gain linked to immunotherapy response in advanced cutaneous squamous cell carcinoma.

Kacew AJ, Harris EJ, Lorch JH, Haddad RI, Chau NG, Rabinowits G, LeBoeuf NR, Schmults CD, Thakuria M, MacConaill LE, Hanna GJ. Kacew AJ, et al. Among authors: leboeuf nr. Eur J Cancer. 2019 May;113:1-9. doi: 10.1016/j.ejca.2019.03.004. Epub 2019 Apr 4. Eur J Cancer. 2019. PMID: 30954880

6

Skin cancer risk in CHEK2 mutation carriers.

Bui AN, LeBoeuf NR, Nambudiri VE. Bui AN, et al. Among authors: leboeuf nr. J Eur Acad Dermatol Venereol. 2021 Feb;35(2):353-359. doi: 10.1111/jdv.16729. Epub 2020 Jul 8. J Eur Acad Dermatol Venereol. 2021. PMID: 32531112 Review.

7

Real-world outcomes treating patients with advanced cutaneous squamous cell carcinoma with immune checkpoint inhibitors (CPI).

Hanna GJ, Ruiz ES, LeBoeuf NR, Thakuria M, Schmults CD, Decaprio JA, Silk AW. Hanna GJ, et al. Among authors: leboeuf nr. Br J Cancer. 2020 Nov;123(10):1535-1542. doi: 10.1038/s41416-020-01044-8. Epub 2020 Sep 1. Br J Cancer. 2020. PMID: 32868898 Free PMC article.

8

Photodynamic therapy for multiple eruptive keratoacanthomas associated with vemurafenib treatment for metastatic melanoma.

Alloo A, Garibyan L, LeBoeuf N, Lin G, Werchniak A, Hodi FS Jr, Flaherty KT, Lawrence DP, Lin JY. Alloo A, et al. Arch Dermatol. 2012 Mar;148(3):363-6. doi: 10.1001/archdermatol.2011.3080. Arch Dermatol. 2012. PMID: 22431777 Clinical Trial.

9

Merkel Cell Carcinoma Presenting as Subcutaneous Breast Masses: An Uncommon Presentation of a Rare Neuroendocrine Neoplasm.

Nambudiri VE, Vivero M, Watson AJ, Thakuria M, Ng A, Russell S, Rabinowits G, LeBoeuf NR. Nambudiri VE, et al. Among authors: leboeuf nr. Breast J. 2016 Jan-Feb;22(1):113-5. doi: 10.1111/tbj.12534. Epub 2015 Nov 25. Breast J. 2016. PMID: 26607182 No abstract available.

10

Programmed cell death-1 pathway inhibitors in genitourinary malignancies: specific side-effects and their management.

Tripathi A, Kaymakcalan MD, LeBoeuf NR, Harshman LC. Tripathi A, et al. Among authors: leboeuf nr. Curr Opin Urol. 2016 Nov;26(6):548-55. doi: 10.1097/MOU.0000000000000332. Curr Opin Urol. 2016. PMID: 27517638 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

152 results

Search Page